September 4-7 2018
Boston, MA


Twitter logo for website footers 2

2017 Speakers

Expand/Collapse

Keynote Experts

James Noble
CEO
Adaptimmune

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

André Choulika
CEO
Cellectis

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

Sunil Agarwal
President R&D
Juno Therapeutics

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

Samuele Butera
Global Head, Cell & Gene Therapies, Business Leader
Novartis

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

Laurence Cooper
CEO
ZIOPHARM Oncology

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

Jacob Plieth
Senior Journalist
EP Vantage

Day One

Wednesday September 6th 2017

08.45-10.15 | Industry Leaders’ Fireside Chat

Philip Vanek
GM Cell Therapy Growth Strategy
GE Healthcare

Day Two

Thursday September 7th 2017

08.45-09.15 | Smart, Closed & Connected Solutions for Cell Therapy Production

Jessi Ayoub
Executive Board
Emily Whitehead Foundation

Day Two

Thursday September 7th 2017

15.50-16.10 | EWF Auction Prize Giving

16.10-16.30 | The 4 Letter C Word: Close of 3rd CAR-TCR Summit

Nicole Gularte
CAR-T Therapy Patient
Inspired Hero

Day Two

Thursday September 7th 2017

09.15-09.45 | Activating the Cure: Ensuring We Put the Patients First

CAR-TCR Discovery Experts

Mark Klinger
PhD, Head of TCR Discovery
Adaptive Therapeutics

Paul Rennert
President & CSO
Aleta Biotherapeutics

Day Two

Thursday September 7th 2017

08.30-08.45 | Opening Remarks & Day 1 Summary

Maksim Mamonkin
Instructor, Pathology & Immunology, Center for Cell & Gene Therapy
Baylor College of Medicine

David Spencer
CSO
Bellicum Pharmaceuticals

James Rottman
Senior Director, Translational Development
bluebird bio

Travis Young
Principal Investigator
CALIBR

Peter Emtage
CSO
Cell Design Labs

Charles Sentman
Director, Center for Synthetic Immunity
The Geisel School of Medicine, Dartmouth

Steffen Walter
CSO
Immatics

Lei Xiao
Founder, President & CSO
Innovative Cellular Therapeutics

Isabelle Rivière
Director, Michael G. Harris Cell Therapy & Cell Engineering Facility,
Memorial Sloan Kettering Cancer Center

Partow Kebriaei
Professor, Department of Stem Cell Transplantation & Cellular Therapy
MD Anderson Cancer Center

Stephanie Goff
Staff Clinician, Surgery Branch, Rosenberg Lab
NCI

Ryan Cawood
CEO & Founder
Oxford Genetics

Steven Shamah
SVP, Head of Research
Obsidian Therapeutics

Jim Freeth
Managing Director
Retrogenix

Yangbing Zhao
Director, T Cell Engineering Laboratory
University of Pennsylvania

Daniel Powell
Director of the Cellular Therapy Tissue Facility, Perelman School of Medicine
University of Pennsylvania

CAR-TCR Translation Experts

Samik Basu
Director, Translational Sciences
Adaptimmune

Chris Haqq
CSO
Atara Biotherapeutics

Philip Gregory
CSO
bluebird bio

Julianne Smith
VP Translational Sciences
Cellectis

Day Two

Thursday September 7th 2017

14.25- 14.55 | Gene Edited Allogeneic CAR T-Cell Therapy

Kristin Baird
Medical Officer, Division of Clinical Evaluation, Tissue & Gene Therapies, CBER
FDA

John Rozembersky
VP Marketing & Application Technologies
FloDesign Sonics

Larry Corey
President & Director Emeritus
Fred Hutchinson Cancer Research Center

Sean Mackay
CEO
Isoplexis

Thomas Duensing
CTO
IntelliCyt

Marcela Maus
Director, Cellular Immunotherapy
Massachusetts General Hospital Cancer Center

Jennifer Brogdon
Director, Exploratory Immuno-Oncology
Novartis

Simon Lacey
Director, Translational & Correlative Studies Laboratory
University of Pennsylvania

Michael Farwell
Assistant Professor, Radiology
University of Pennsylvania

Devon Shedlock
Senior Director, Immuno-Oncology
Poseida Therapeutics

Vita Golubovskaya
Director, R&D
ProMab Biotechnologies

Steven Katz
Director, Office of Therapeutic Development
Roger Williams Cancer Center

Rob Hofmeister
CSO
TCR2 Therapeutics

Alexey Bersenev
Director, Advanced Cell Therapy Lab
Yale University

CAR-TCR Manufacturing Experts

Yama Abassi
VP, Global Strategic Business Development
ACEA Biosciences

Michael Blackton
VP, Quality Affairs, CMC
Adaptimmune

Claudia Zylberberg
CEO
Akron Biotech

Qinhua Cindy Ru
VP & CSO
CARsgen Therapeutics

Mark Davis
Procurement Director
CAR-T Strategic Sourcing Expert

David Sourdive
EVP, Technical Operations
Cellectis

Jenna Balestrini
Senior Member Technical Staff
Draper Laboratories

Jeffrey Borenstein
Laboratory Technical Staff
Draper Laboratories

Jakob Reiser
Principal Investigator
CBER, FDA

Bala Manian
Executive Chairman
LeukoDx Inc

Nina Bauer
Commercial Development Lead, Autologous Cell Therapy
Lonza

Boro Dropulic
CSO
Lentigen Technology, A Miltenyi Biotec Company

Markus Dangl
SVP, Research & Pre-Clinical Development
Medigene

Arnab Ghosh
Hematology & Medical Oncology Fellow
Memorial Sloan Kettering Cancer

Rodney Rietze
Lead, cGMP Process Automation
Novartis

Therese Choquette
Fellow, Cell & Gene Bio Analytics
Novartis

Bruce Levine
Director, Clinical Cell & Vaccine Production Facility
Perelman School of Medicine, University of Pennsylvania

Geoff Hodge
CTO
Unum Therapeutics

CAR-TCR Commercialization Experts

Helen Tayton-Martin
CBO
Adaptimmune

Molly McCormick
VP, Case Management & Operations Services
Be The Match BioTherapies

Robert Tressler
VP, Laboratories, San Diego Blood Bank, on behalf of
Blood Centers of America

Shawn Foley
Attorney, Intellectual Property
Burns & Levinson

Jennifer Fillman
Vice President, General Manager
Cardinal Health Specialty Solutions

Jennifer Fillman is Vice President and General Manager for Cardinal Health Specialty Solutions. She oversees capabilities in access and patient support, healthcare marketing and analytics, third party logistics and strategic accounts. She offers biopharma clients solutions that leverage the integrated value of Cardinal Health services to help drive success for their specialty products. Fillman has been with Cardinal Health for more than 20 years and throughout her career has held a series of financial leadership and senior management positions. She serves on the board of BioOhio, a non-profit membership organization focused on accelerating bioscience discovery, innovation, education, research and commercialization, driving economic growth and improved quality of life in Ohio.

Mark Sawicki
CCO
Cryoport

Rena Conti
Departments of Pediatrics Hematology/Oncology & Health Studies
The University of Chicago

Lauren Gurschick
Nurse Practitioner, Engineered Cell Therapy,
Dana-Farber Cancer Institute

Phyllis Warkentin
CMO
Foundation for the Accreditation of Cellular Therapy

Aaron Levine
Associate Professor, School of Public Policy
Georgia Tech

Anna Cameron
Market Access & Healthcare Solutions Director, Oncology
GSK

Sadik Kassim
VP, Head, Development
Mustang Bio

Heidi Hagen
Co-Founder & CSO
Vineti

James Connolly
Business Development Manager
World Courier